𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and Histopathologic Response to Various Treatment Interventions in Patients with EE

✍ Scribed by Chhabra, A.; Matsui, E.C.; Wood, R.A.

Book ID
119282130
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
40 KB
Volume
123
Category
Article
ISSN
1097-6825

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Histopathologic and clinical outcome of
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn JΓ³nsdΓ³ttir; Stefan H. Jacobson; Elisa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose